A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Participants
Clinical trial NCT03224325 · COMPLETED
Trial details
- NCT number
- NCT03224325
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-21
- Primary completion
- 2018-09-09
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.